期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

慢性阻塞性肺疾病治疗中新型支气管扩张剂研究进展 被引量：21

Emerging bronchodilators for the treatment of chronic obstructive pulmonary disease:summary of research progress
原文传递
导出
摘要 慢性阻塞性肺疾病（COPD）是可以预防和治疗的。支气管扩张剂是目前治疗COPD的主要药物，包括β2受体（AR）激动药（LABA）、茶碱类药、抗胆碱能类药等。因为支气管扩张剂在治疗呼吸类疾病中处于中心地位，所以许多大医药公司仍然投入巨资研发新的支气管扩张剂以及复方制剂。本文综述了一些新型支气管扩张剂的研究进展。
作者 王卫 陈燕明
机构地区 南京医科大学附属苏州医院呼吸内科
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2013年第2期161-163,共3页 Chinese Journal of Practical Internal Medicine
关键词 慢性阻塞性肺病 支气管扩张剂 联合用药 chronic obstructive pulmonary disease bronchodilator combination medication
分类号 R563.05 [医药卫生—呼吸系统]
  • 相关文献

参考文献17

  • 1赵红梅,毛毅敏.急性加重期慢性阻塞性肺疾病28例治疗体会[J].郑州大学学报（医学版）,2007,42(4):788-789. 被引量：6
  • 2Sturton RG, Trifilieff A, Nicholson AG, et al. Pharmacological char- acterization of indacaterol, a novel once daily inhaled 132 adrenocep-tor agonist, on small airways in human and rat precision-cut lung slices [ J ]. J Pharmacol Exp Ther,2008,324,70 - 75.
  • 3Barrett V J, Morrison V, Sturton RG, et al. Pharmacological character- isation of GW642444, a long-acting 132-agonist ( LABA ) with rapid onset and long duration,on isolated large and small human airways [J]. Am J Respir Crit Care Med,2010,181 ,A4453.
  • 4Hanania H, Feldman G, Zachgo W, et al. Dose-related efficacy of vilanterol trifenatate in COPD [ J ]. Eur Respir J, 2010,36,217 - 221.
  • 5Bouyssou T, Casarosa P, Naline E, et al. Pharmacological character- ization of Olodaterol, a ovel Inhaled 132 adrenoceptor agonist exerting a 24-hour-long duration of action in preclinical models [ J ]. J Phar- macol Exp Ther,2010,334,53 - 62.
  • 6VanNoord JA, Smeets JJ, Drenth BM, et al. 24-hour bronchodilation following a single dose of the novel 132-agonist olodaterol in COPD [ J ]. Pulm Pharmacol Ther,2011,24,666 - 672.
  • 7Mason KP, Zgleszewski S, Forman RE, et al. An Exaggerated hyper- tensive response to glycopyrrolate therapy for bradycardia associated with high-dose dexmedetomidine [ J ]. Anesth Analg, 2009, 108 : 906 - 908.
  • 8Sentellas S, Ramos I, Alberti J, et al. Aclidinium bromide, a new, long-acting,inhaled muscarinic antagonist:in vitro plasma inactiva- tion and pharmacological activity of its main metabolites [ J ]. Eur J Pharm Sci ,2010,39:283 - 290.
  • 9Page CP. Doxofylline:A "Novofylline" [ J]. Pulm Pharmacolo Ther, 2010,23,231 -234.
  • 10Fabbri LM, Calverley PM, Izquierdo-Alonso JL, et al. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with long-acting bronchodilators: two randomized clinical trials [ J]. Lancet ,2009,374:695 - 703.

二级参考文献14

  • 1[3]Dorinsky PM,Reisner C,Ferguson GT,et al.The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in pa-tients with COPD[J].Chest,1999,115(4):996
  • 2[4]Oga T,Nishimura K,Tsukino M,et al.A comparison of the effects of sal-butamol and ipratropium bromide on exercse endurance in patients with COPD[J].Chest,2003,123(6):1 810
  • 3Nici L, Donner C, Wouters E, et al. ATS/ERS Pulmonary Rehabili- tation Writing Committee. American Thoracic Society/European Re- spiratory Society statement on pulmonary rehabilitation [ J ]. Am J Respir Crit Care Med ,2006,173 : 1390 - 1413.
  • 4American Association of Cardiovascular and Pulmonary Rehabilita- tion. Guidelines for pulmonary rehabilitation programs [ M ]//Zu- Wallack RZ, Crouch R. Human kinetics,3rd ed. Champaign, IL:Hu- man Kinetics ,2004:4 - 10.
  • 5Puhan MA, Scharplatz M, Troosters T, et al. Respiratory rehabilita- tion "after acute exacerbation of COPD may reduce risk for readmis- sion and mortality:a systematic review [ J 1. Respir Res,2005 ,6 :54.
  • 6Swallow EB, Reyes D, Hopkinson NS, et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic ob- structive pulmonary disease [ J ]. Thorax,2007,62 ( 2 ) : 115 - 120.
  • 7Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary rehabilitation: joint ACCP/AACVPR evidence based clinical practice guidelines [Jl. Chest,2007,131 (5 Suppl) :4S -42S.
  • 8Saey D, Maltais F. Role of peripheral muscle function in rehabilita- tion[ M 1//Donner CF, Ambrosino N, Goldstein RS ( eds ). Puhno- na13, rehabilitation. London : Arnold Pub,2005 : 80 - 90.
  • 9Puhan MA, Busching G, Schunemann JH, et al. Interval versus con- tinuous high-intensity exercise in chronic obstructive pulmonary dis- ease : a randomized controlled trial [ J 1. Ann Intern Med, 2006,145 (11) :816 -825.
  • 10Global strategy for the diagnosis, management and prevention of COPD : 2007 update [ J ]. Eur Respir J. updated,2007 : 56.

共引文献23

同被引文献232

引证文献21

二级引证文献279

中国实用内科杂志
2013年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部